AF
ALNY icon

Advisornet Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Advisornet Financial’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.42K Buy
18
+14
+350% +$4.22K ﹤0.01% 1745
2026
Q1 		$1.32K Sell
4
-2
-33% -$681 ﹤0.01% 1973
2025
Q4 		$2.39K Sell
6
-15
-71% -$6.64K ﹤0.01% 1880
2025
Q3 		$9.58K Buy
21
+18
+600% +$7.33K ﹤0.01% 1533
2025
Q2 		$978 Hold
3
– – ﹤0.01% 1946
2025
Q1 		$810 Hold
3
– – ﹤0.01% 1909
2024
Q4 		$706 Sell
3
-8
-73% -$2.1K ﹤0.01% 1719
2024
Q3 		$3.02K Buy
11
+1
+10% +$260 ﹤0.01% 1683
2024
Q2 		$2.43K Sell
10
-13
-57% -$2.05K ﹤0.01% 1594
2024
Q1 		$3.44K Buy
23
+15
+188% +$2.5K ﹤0.01% 1510
2023
Q4 		$1.53K Sell
8
-1
-11% -$170 ﹤0.01% 1786
2023
Q3 		$1.59K Sell
9
-15
-63% -$2.86K ﹤0.01% 1698
2023
Q2 		$4.56K Sell
24
-10
-29% -$1.98K ﹤0.01% 1528
2023
Q1 		$6.81K Buy
34
+27
+386% +$5.67K ﹤0.01% 1403
2022
Q4 		$1.66K Buy
7
+5
+250% +$1.07K ﹤0.01% 1711
2022
Q3 		$0 Buy
+2
New +$381 ﹤0.01% 1855

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisornet Financial's ALNY Position: Q2 2026 in Review

Advisornet Financial increased its Alnylam Pharmaceuticals (ALNY) stake by 350% in Q2 2026, buying an estimated $4.22K and bringing the position to 18 shares worth $5.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1745.

Advisornet Financial first reported a position in ALNY in Q3 2022 and has held it in 16 quarters since. The position peaked at $9.58K in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Advisornet Financial held 18 shares of Alnylam Pharmaceuticals worth $5.42K as of Q2 2026.
  • Advisornet Financial bought 14 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $4.22K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1745 holding.
  • Advisornet Financial first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Advisornet Financial's Alnylam Pharmaceuticals position peaked at $9.58K in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.